The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $97.
Wells Fargo
WFC · a US exchange · USD · Market cap $254.6B · 200,999 employees
Wells Fargo & Company, a financial services company, provides diversified banking, investment, mortgage, and consumer and commercial finance products and services in the United States and internationally.
FAIL · Does not pass the screenPrice as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 18:06 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price85.53 USD at the 3 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 3 Nov 2026
- Our regime readAccumulation, as of 3 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 1.90)
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $90.13 to $150.22, base estimate $107.59 (screen dated 2026-11-03).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-09-25
- Options put/call open interest 1.90, read 2026-11-01
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Wells Fargo holds its Accumulation at $85.53. The statistical read favours the buyers, held for 1 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 1 days |
| Price at the screen | $85.53 |
| Valuation | 11.96 trailing · 10.59 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.95 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Wells Fargo does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when WFC's ethical verdict changes
Today WFC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on Palestinian BDS National Committee — category: Institutional Pressure / Financial. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 3 Nov 2026: it trades at roughly a 20% discount to our $107.59 fair value, moderate competitive moat, 0.40% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. A 20.5% discount to the base estimate.
Third-party analyst targets: 24 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $107.59, with a range of $90.13 to $150.22, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWells Fargo, a Fallen Giant That Fails to Meet Ethical Standards
Wells Fargo is a familiar name in financial services, with its sprawling reach across the United States and international presence. But when you take a transaction at the local bank, little do you know, it's failing our ethical screen. The bank's activities are not up to par, and that's why it stands out - for all the wrong reasons.
Despite its low forward P/E ratio of 10.6x, which might seem like a steal, and a decent 10% revenue growth, Wells Fargo falls short in another crucial area - ethical standards. The market consensus is overwhelmingly bullish, with a median target price of $102, but the ethical failings can't be overlooked. This is a bank with a profit margin of 27% and a ROE of 13%, yet it's missing where it truly counts - in ethical practice.
Risks are high here, and not just from a financial standpoint. With a MODERATE moat and a failed business activity screen, Wells Fargo presents a significant ethical risk. It's not just about the numbers; it's about doing business the right way. And in this case, Wells Fargo is falling short. Analysis, not advice.
| Forward P/E | 10.6xexpensive even after accounting for its growth |
| Trailing P/E | 12.0xreasonably valued |
| EPS, trailing | 7.09 |
| EPS, forward | 8.01 |
| Revenue growth | +0.4%slow but positive growth |
| Profit margin | 27.6%healthy profit margins |
| Return on equity | 12.9%a solid return on shareholder capital |
| Dividend yield | 238.00% |
| Beta | 0.95steadier than the market |
| 52-week range | 72.78 - 97.76 |
| Moat | MODERATE |
| Market cap | $254.6B |
| Employees | 200,999 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeWFC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $97.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $97.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $99. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $99. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $99. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (24 analysts) rates it buy, with a mean price target of $99. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it buy, with a mean price target of $101.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (23 analysts) rates it buy, with a mean price target of $101.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (22 analysts) rates it buy, with a mean price target of $96.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Black Cultural Zone CDC and Eden Housing Break Ground on $135 Million Affordable Housing Development in East Oakland Yahoo Finance · 23h ago
- AI Debt is Hitting Record Levels at the Worst Possible Time Yahoo Finance · 1d ago
- Will Citigroup's Cost-Cut Initiatives Boost Long-Term Profitability? Yahoo Finance · 1d ago
- Wells Fargo Leads NYC Lenders as Top 20 Originate $36B Yahoo Finance · 2d ago
- Wells Fargo wants customers to prove they've revoked AI agents Yahoo Finance · 2d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | Patterson Ellen R | Sr. EVP, GC | Sale | 60,000 | $5,244,000 |
| 2026-02-26 | Engle Bridget E. | Sr. EVP | Sale | 30,000 | $2,613,000 |
| 2026-02-20 | Santos Kleber | Sr. EVP | Sale | 25,000 | $2,193,000 |
| 2026-05-14 | CRAVER THEODORE F JR | Director | 89 | · | |
| 2026-03-05 | SCHARF CHARLES W | Chief Executive Officer | 379,767 | · | |
| 2026-03-05 | SANTOS KLEBER | Officer | 60,914 | · | |
| 2026-03-05 | FERCHO KRISTY | Officer | 25,823 | · | |
| 2026-03-05 | VAN BEURDEN SAUL | Officer | 88,175 | · | |
| 2026-03-05 | SANTOMASSIMO MICHAEL P | Chief Financial Officer | 125,481 | · | |
| 2026-03-05 | PATTERSON ELLEN REILLY | General Counsel | 97,258 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-17 | Ro Khanna | Democrat | buy | 15K–50K |
| 2026-09-17 | Ro Khanna | Democrat | buy | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $73.58 | +11.4% | · | $1,114 | +11.4% |
| 2 months | $84.91 | -3.5% | $0.45 | $971 | -2.9% |
| 3 months | $74.82 | +9.6% | $0.45 | $1,102 | +10.2% |
| 6 months | $91.61 | -10.5% | $0.90 | $905 | -9.5% |
| 1 year | $73.83 | +11.0% | $1.80 | $1,135 | +13.5% |
| 2 years | $55.36 | +48.1% | $3.40 | $1,542 | +54.2% |
| 3 years | $39.09 | +109.7% | $4.80 | $2,220 | +122.0% |
| 5 years | $40.50 | +102.4% | $6.90 | $2,194 | +119.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever WFC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.